Caris Life Sciences, Inc. Common Stock(CAI)— 技术面状态
数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +9.6% vs the 50-day and +48.6% vs the 200-day average, 12.1% below the 52-week high and +126.2% off the 52-week low; a golden cross printed 34 sessions ago. Computed from daily closes.
Ranked #5 on today’s Directional Flow — Rising fastest list (scan of 2026-11-02).
均线状态
- 相对20日均线+2.6%
- 相对50日均线+9.6%
- 相对200日均线+48.6%
- 52周区间低于52周高点12.1% · 高于52周低点126.2%
- 连续走势连续2个交易日下跌
- 均线交叉金叉(34个交易日前)
- 50日均线交叉股价向上穿越50日均线(61个交易日前)
- 随机指标%K 42.9 · %D 85.3(死叉)
FAQ · from the current data · as of 2026-11-02
Quick answers
CAI当前的Closelook信号是什么?
Uptrend stack intact — Trades +9.6% vs the 50-day and +48.6% vs the 200-day average, 12.1% below the 52-week high and +126.2% off the 52-week low; a golden cross printed 34 sessions ago. Computed from daily closes.(截至2026-11-02;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
CAI目前是否位于50日和200日均线上方?
截至2026-11-02,Caris Life Sciences, Inc. Common Stock位于50日均线上方(+9.6%),200日均线上方(+48.6%);距20日均线+2.6%。
CAI距52周高点有多远?
截至2026-11-02,低于52周高点12.1%,高于52周低点126.2%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry